[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,488
Sort by:

Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016

US$ 975.00

Hepatitis C virus drug market is experiencing a dramatic near-term growth, by crossing US$ 6 Billion in 2011 and is expected to be more than double of its current figure by 2015. This robust growth wi...

January 2012 72 pages

Outsourcing in Drug Development: The Contract Research (Clinical Trial ) Market

US$ 3,995.00

... can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to ... (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion ...

January 2012 235 pages

Antithrombotic/Anticoagulant Drugs: World Market 2012-2022

US$ 2,635.00

... presentations. You will find answers in our work. Revenue forecasts, market shares, developmental trends, discussions and interviews In the report you ... charts and four research interviews. Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work In particular, this study ...

January 2012 120 pages

Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market

US$ 560.00

The present report entitled “Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market”, discuss market size (historical, present and future) of the Japanese pharmaceutic...

January 2012 53 pages

Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?

US$ 595.00

Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market. Already established there since 2006, biosimilars are set to be...

November 2011 47 pages

Generic Drug Market in Canada

US$ 1,000.00

Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...

November 2011 65 pages

Multiple Sclerosis Treatment: World Drug Market 2012-2022

US$ 2,635.00

... tables and charts and three research interviews. Advantages of Multiple Sclerosis Treatment: World Drug Market 2012-2022 for your work Our ... , viewing sales growth Discover revenue forecasts to 2022 for leading MS drugs, assessing commercial potential Assess leading companies, discovering their activities ...

November 2011 116 pages

Rheumatoid Arthritis: Battlefield At ACR '11 - Next Wave: Innovative Oral Drugs for RA

US$ 1,200.00

... to moderate RA pts population where biologics have not made a dent. At ACR 2011 (Nov. 5-9, 2011, Chicago), key data on safety and efficacy ... read our meeting preview report released on 1st Nov, 2011 on “Rheumatoid Arthritis: Battlefield at ACR ’11 - Next Wave: Innovative Oral Drugs for RA”.

October 2011 11 pages

Hepatitis C: Battlefield at AASLD ‘11 - Next Wave: IFN-Free Drugs with Safety and Dosing Advantage

US$ 2,000.00

... Study of Liver Diseases (AASLD) 2011 (Nov. 4 - Nov. 8, San Francisco) will unveil - Data and new approaches to treat Hepatitis C Viral Infection (HCV ... our Therapeutic Class Overview report released on 31st October, 2011 on Hepatitis C: AASLD 2011 titled “Next Wave: IFN-Free Drugs with Safety ...

October 2011 13 pages

The UK Vitamin and Dietary Supplements Demand and Forecast

US$ 630.00

Executive summary The UK is one of the developed countries of Western Europe and has a well-formed nutrients & supplements market in the world. The industry has been registering growth primarily...

September 2011 36 pages

Global Osteoporosis Market & Drugs Analysis 2010 - 2015

US$ 950.00

Osteoporosis Market Overview Osteoporosis is often called the ""silent disease"" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-archite...

September 2011 72 pages

Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers

US$ 7,840.00

... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...

September 2011 1353 pages

Global CNS Drug Market: Strategic Assessments of Leading Suppliers

US$ 7,840.00

... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...

September 2011 1353 pages

Global Oncology Drug Market: Strategic Assessments of Leading Suppliers

US$ 7,840.00

... information and analysis of the leading players in the Global Oncology Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...

September 2011 1353 pages

Emergency Contraception in Ukraine

US$ 990.00

... simply unable to afford emergency contraception, particularly as unregulated prices resulted in a wide variance in price across chemists/pharmacies. Euromonitor International's Emergency Contraception in Ukraine report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...

September 2011 19 pages

Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis

US$ 2,632.00

... Product description This report “Antibody-Drug Conjugates 2011 – real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis” published in September ... still narrow the therapeutic window for the currently used drugs and linkers. Nevertheless, about half of the currently clinical stage ...

September 2011 274 pages

Europe Vitamin and Dietary Supplements Demand and Forecast

US$ 850.00

Executive summary Europe is considered to be one of the largest markets for nutrients & supplements in the world. In the European region, Western Europe which is one of the most developed markets...

August 2011 51 pages

Booming Generics Drug Market in India

US$ 1,000.00

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,800.00 Hard Copy: US$ 1,200.00 CD-ROM: US$ 1,200.00 The world has witnessed a sharp increase in the demand for cost-effec...

August 2011 60 pages

Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)

US$ 850.00

Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bizarre delu...

August 2011 65 pages

Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

US$ 3,500.00

Prices: Single User PDF: US$ 3,500.00 Departmental Site License (one location, up to 10 users): US$ 4,995.00 Global Site License: US$ 7,000.00 The line between drug delivery and drug substance will...

July 2011 105 pages

U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011

US$ 7,495.00

Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...

July 2011 80 pages

International Hyaluronic Acid Viscosupplementation Physician Survey 2011

US$ 11,495.00

Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...

July 2011 91 pages

Generic Drugs in Consumer Health Global Overview 2011

US$ 2,000.00

... are slowly becoming an ally in a strategy to boost sales. Euromonitor International’s Generic Drugs in Consumer Health Global Overview 2011 global briefing examines the ... data. Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving ...

July 2011 50 pages

Global Obesity Drug Market Analysis

US$ 1,000.00

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The obesity epidemic has been disseminating among developed countries as well as low...

June 2011 85 pages

Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 - 2015) & Drugs Analysis

US$ 950.00

Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, but it stil...

June 2011 95 pages

Drug Combinations: New Rules, New Opportunities

US$ 895.00

Single symptom. Single illness. Single drug. For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease patholo...

May 2011 48 pages

China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration

US$ 1,495.00

China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2006, sales on the Chinese drug market have reached $12 billion dollars, an increase of 3.8...

May 2011 286 pages

Vitamins and Dietary Supplements in Indonesia

US$ 900.00

Vitamins and dietary supplements continued to record healthy double-digit current retail value growth in 2010, with sales being boosted by the increasing popularity of preventive medicine, especially...

May 2011 44 pages

Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021

US$ 2,325.00

... and a research interview (shown in the accompanying lists). Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 shows you revenue ... technologies in development, assessing potential among the R&D product candidates for ACS You will investigate competition and opportunities influencing the industry ...

May 2011 132 pages

Global Alzheimer Prevalence and Drugs Demand

US$ 630.00

EXECUTIVE SUMMARY The report on “Global Alzheimer Prevalence and Drugs Demand” includes the overall market for the treatment of Alzheimer, performance of drugs by sales and market share. In...

April 2011 37 pages

Production, Market and Benchmarking of Synthetic Vitamin E in China

US$ 14,897.00

... vitamin E producers’ competitiveness in China, CCM did production benchmarking analysis of three major vitamin E producers in China. What is the detailed ... in China in 2011? This report combines CCM’s expertise in vitamin E market research. Aspects as follows can be expected: Production situation ...

April 2011 57 pages

Bangladesh Vitamins & Minerals Market Report & Forecasts

US$ 675.00

IMARC’s new report “Bangladesh Vitamins & Minerals Market Report & Forecasts” provides an analytical and statistical insight into the Bangladesh vitamins and minerals market. The report provides both...

April 2011 147 pages

Competitor Analysis: Emerging Diabetes Drugs

US$ 870.00

Product description The present Competitive Intelligence Report about Emerging Diabetes Drugs provides a competitor evaluation in the field of novel molecules against a series of novel targets being developed for treatment of type 1 or 2 diabetes as of April 2011. Pharmacologic approaches include SGLT ...

April 2011 104 pages

World Diabetes Drug Market 2011-2021

US$ 2,325.00

... , Levemir, Actraphane HM, Actos, Avandia, Avandamet, Januvia and Byetta will perform to 2021. We also discuss insulin delivery technologies. Our review of research and ... for you to stay ahead in this industry and market. World Diabetes Drug Market 2011-2021 shows you revenue trends, opportunities and ...

March 2011 224 pages

Analgesics - Hong Kong, China

US$ 900.00

Analgesics continued to see steady growth in value sales in 2010, of 4%, which was in line with the review period average. Growth was driven by a strong performance by topical analgesics. Eur...

March 2011 25 pages

Calming and Sleeping - Czech Republic

US$ 900.00

Calming and sleeping recorded a healthy review period current retail value CAGR of 3%. Consumption in this area is being fuelled by the fact that the increasingly hectic and stressful pace of modern l...

March 2011 24 pages

Calming and Sleeping - Hong Kong, China

US$ 900.00

The high stress levels experienced by many Hong Kong residents is believed to be the main factor causing insomnia. Some people purchase over-the-counter products for treatment; however, many simply se...

March 2011 23 pages

Cough, Cold and Allergy (Hay Fever) Remedies - Czech Republic

US$ 900.00

Cough, cold and allergy remedies posted satisfactory current retail value growth of 4% in 2010, with demand being boosted by the relatively long winter and exceptionally cold spring in 2010 and the co...

March 2011 28 pages

Cough, Cold and Allergy (hay Fever) Remedies - Hong Kong, China

US$ 900.00

Flu viruses continued to be quite prominent in 2010. The media reported incidences of upper respiratory tract infection (URI) and influenza outbreaks in schools and child care centres throughout the y...

March 2011 27 pages

Digestive Remedies - Czech Republic

US$ 900.00

Digestive remedies recorded relatively stable growth over the review period, with constant retail value sales increasing at an average annual rate of 3%. The consumption of digestive remedies is being...

March 2011 26 pages

Digestive Remedies - Hong Kong, China

US$ 900.00

In March 2010, the Department of Health ordered that all products from Li Chung Shing Tong (Holdings) Ltd, including Po Chai Pills Capsule Form and Po Chai Pills Bottle Form, be recalled from local re...

March 2011 25 pages

NRT Smoking Cessation Aids - Czech Republic

US$ 900.00

NRT smoking cessation aids recorded good current retail value growth of 2% in 2010. Although products in this area are relatively expensive, quitting smoking is an excellent way of reducing household...

March 2011 26 pages

NRT Smoking Cessation Aids - Hong Kong, China

US$ 900.00

In 2010, the government launched a TV advertising campaign to promote a smoke-free culture. Since 2007, the government has been gradually increasing the number of places where smoking is prohibited. C...

March 2011 24 pages

Vitamins and Dietary Supplements - Czech Republic

US$ 900.00

Vitamins and dietary supplements current retail value growth of 4% in 2010 was slightly higher than the review period average of 3%, with demand being fuelled by rising consumer health awareness and i...

March 2011 33 pages

Vitamins and Dietary Supplements - Hong Kong, China

US$ 900.00

In 2010, various industry players advertised heavily in newspapers and on TV, driving the overall growth of vitamins and dietary supplements sales. Consumers are becoming more aware of products such a...

March 2011 31 pages

The Market for Rx to OTC Switches

US$ 3,500.00

Price (Single User PDF): $3,500.00 Price (Global Site License): $7,000.00 While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the cou...

February 2011 280 pages

World Anti-Obesity Drug Market 2011-2021

US$ 2,325.00

... and two interviews (shown in the accompanying lists). World Anti-Obesity Drug Market 2011-2021 shows you revenue trends, opportunities and challenges ... products You will investigate commercial requirements - with therapeutic needs and market opportunities discussed You will view expert opinion from our ...

February 2011 209 pages

Top 10 Drug Delivery Technologies Market

US$ 5,650.00

... to arrive at top 10 drug delivery technologies. The key drug delivery technologies discussed in the report are: Oral drug delivery technologies Injectable drug delivery technologies Pulmonary drug delivery technologies Transdermal drug delivery technologies Other drug delivery technologies The report also ...

February 2011 388 pages

Global Injectable Drug Delivery Market (2010 - 2015)

US$ 5,650.00

... on market dynamics, increasing innovation from alternative technologies and threat from competitors in injectable drug delivery market to sustain their market position. This report highlights the global injectable drug delivery market segmented as below Injectable systems (Sustained Release Injectable Systems, Needleless Systems ...

February 2011 253 pages

Competitor Analysis: Insulin

US$ 616.00

Product description The Competitive Intelligence Report Insulin as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant insulin and insulin analogs for the treatment of type 1 and type 2 diabetes mellitus. Purchase of the pdf report includes ...

January 2011 73 pages

Filters

Search

Publishers

1
174
29
2
1
64
4
1
27
16
5
13
1
3
9
2,264
5
4
22
51
6
142
16
1
17
1
15
22
651
79
1
373
16
586
4
1
1
2
16
1,197
6
166
4
84
31
2
36
3
5
4
118
187
13
16
4
2
7
15
110
2
10
50
16
26
4
2
17
4
2
1
11
32
8
16
4
23
118
52
2
1
19
4
7
3
324
11
1
1
23
31
4
11
5
1
514
24
2
5
30
44
294
17
17
13
5
18
2

Regions

277
157
54
51
45
43
41
41
20
18
17
17
16
16
15
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
12
11
11
11
10
10
10
9
9
8
8
7
6
6
5
4
3
9
5
4
11
5
8
4
8
7
11
8
586
192
10
8
4
4
4
4
4
3
3
3
3
3
3
1
1
9
8
2
3
183
3
11
14
11
3
16
9
6
16
14
7
150
248
5,544
11

Price

Date

Pages

Offers

13
2
9
1
513